Atlas Trials

Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer

Clinical trial NCT00176488 · TERMINATED

Trial details

NCT number
NCT00176488
Sponsor
University of Medicine and Dentistry of New Jersey
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2003-06-01
Primary completion
2009-10-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.